Skip to main content
World Drug Report 2025 (Set of 3 Booklets)

World Drug Report 2025 (Set of 3 Booklets)

By United Nations Office on Drugs and Crime

Published by United Nations

English 239 pages 2025 ISBN 9789211594850
Estimated reading time: 4 h 23 min
PDF

About this book

A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2025 comprises several elements tailored to different audiences. Key findings provide an overview of selected findings from the analysis presented in Drug market patterns and trends and the thematic chapters of Contemporary issues on drugs, while Special points of interest offer a framework for the main takeaways and policy implications that can be drawn from those findings. The World Drug Report 2025 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also at assisting Member States in anticipating and addressing threats posed by drug markets and mitigating their consequences.

Availability

World Drug Report 2025 (Set of 3 Booklets) is available as PDF at 11 online bookshops. Bookshops carrying it include Bajalibros Argentina, Bajalibros Latam, Bookshop Uruguay.

Language
English
Share

Frequently asked questions

In what formats is World Drug Report 2025 (Set of 3 Booklets) available?
World Drug Report 2025 (Set of 3 Booklets) is available as PDF at 11 online bookshops.
Where can I buy World Drug Report 2025 (Set of 3 Booklets)?
You can buy World Drug Report 2025 (Set of 3 Booklets) at Bajalibros Argentina, Bajalibros Latam, Bookshop Uruguay. Compare every option in the list on this page.
How long does it take to read World Drug Report 2025 (Set of 3 Booklets)?
At an average reading pace, World Drug Report 2025 (Set of 3 Booklets) takes about 4 h 23 min to read (239 pages).

Ratings & reviews

No ratings yet. Be the first to review this book.

Sign in to rate and review this book.

Comments

Sign in to join the conversation.

No comments yet.